- Latest available (Revised)
- Point in Time (31/12/2020)
- Original (As made)
The Plant Protection Products (Fees and Charges) Regulations 2011
You are here:
- UK Statutory Instruments
- 2011 No. 2132
- SCHEDULE 2
What Version
Advanced Features
- Show Geographical Extent(e.g. England, Wales, Scotland and Northern Ireland)
- Show Timeline of Changes
More Resources
Changes over time for: SCHEDULE 2
Alternative versions:
- 24/09/2011- Amendment
- 06/04/2016- Amendment
- 31/12/2020- Amendment
- 31/12/2020
Point in time
Status:
Point in time view as at 31/12/2020.
Changes to legislation:
There are currently no known outstanding effects for the The Plant Protection Products (Fees and Charges) Regulations 2011, SCHEDULE 2.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Regulation 4(2)
[F1SCHEDULE 2U.K.Import tolerance [F2fees and standalone MRL application fees]
This schedule has no associated Explanatory Memorandum
Textual Amendments
F1Sch. 2 substituted (6.4.2016) by The Plant Protection Products (Fees and Charges) (Amendment) Regulations 2016 (S.I. 2016/254), regs. 1, 2(3)
F2Words in Sch. 2 heading substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 1 para. 15(2); 2020 c. 1, Sch. 5 para. 1(1)
[F3Fees for import tolerances ]U.K.
[F41.] [F5Fees chargeable by a Great Britain competent authority for import tolerances] are in accordance with the following table.
| Item | Category | Fee(£) |
|---|---|---|
| [F6A1 | Preliminary consideration of an application to determine whether the application can proceed further | 229 |
| A2 | Co-ordination of applications | 1,872] |
| 1 | Full Human health description(1) | 16,224 |
| 2 | Metabolism and residues evaluation(2) | 6,760 |
| 3 | Residues evaluation(3) | 2,028 |
Notes
(1) [F7This category is mainly for active substances not currently approved in respect of the part of Great Britain to which the application relates. In certain cases it may also include active substances still being reviewed if toxicological endpoints have not yet been agreed and accepted in respect of that part of Great Britain.]
(2) This category is for [F8active substances] where toxicological endpoints have already been agreed [F9and accepted in respect of the part of Great Britain to which the application relates], but the residue definition has only been established for crop groups unrelated to the intended use or imported produce.
(3) This category is for [F10active substances] where relevant toxicological endpoints and residue definition have already been agreed [F11and accepted in respect of the part of Great Britain to which the application relates].
[F12Fees for multiple import tolerances for the same active substance are calculated on a modular basis with a charge applied for each crop.]]
Textual Amendments
F3Sch. 2 para. 1 heading inserted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 1 para. 15(3); 2020 c. 1, Sch. 5 para. 1(1)
F4Sch. 2 para. 1: Sch. 2 renumbered as Sch. 2 para. 1 (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 1 para. 15(4); 2020 c. 1, Sch. 5 para. 1(1)
F5Words in Sch. 2 para. 1 substituted (31.12.2020) by S.I. 2019/720, Sch. 1 para. 15(5)(a) (as substituted by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 1 para. 11(2)(a))
F6Sch. 2 para. 1 Table Item A1, A2 inserted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 1 para. 15(5)(b); 2020 c. 1, Sch. 5 para. 1(1)
F7Sch. 2 para. 1 Note 1 substituted by S.I. 2019/720, Sch. 1 para. 15(5)(c)(i) (31.12.2020) (as amended by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 1 para. 11(2)(b)(i))
F8Words in Sch. 2 para. 1 Note 2 substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 1 para. 15(5)(c)(ii)(aa); 2020 c. 1, Sch. 5 para. 1(1)
F9Words in Sch. 2 para. 1 Note 2 substituted (31.12.2020) by S.I. 2019/720, reg. 1(2), Sch. 1 para. 15(5)(c)(ii)(bb) (as amended by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 1 para. 11(2)(b)(ii)); 2020 c. 1, Sch. 5 para. 1(1)
F10Words in Sch. 2 para. 1 Note 3 substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 1 para. 15(5)(c)(iii)(aa); 2020 c. 1, Sch. 5 para. 1(1)
F11Words in Sch. 2 para. 1 Note 3 substituted (31.12.2020) by S.I. 2019/720, reg. 1(2), Sch. 1 para. 15(5)(c)(iii)(bb) (as amended by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 1 para. 11(2)(b)(ii)); 2020 c. 1, Sch. 5 para. 1(1)
[F13Fees for standalone MRL applicationsU.K.
2. Fees chargeable by a Great Britain competent authority for standalone MRL applications are in accordance with the following table.
| Item | Category | Fee (£) |
|---|---|---|
| 1 | Preliminary consideration of an application to determine whether the application can proceed further | 229 |
| 2 | Co-ordination of applications | 1,872 |
| 3 | Full human health description(1) | 16,224 |
| 4 | Metabolism and residues evaluation(2) | 6,760 |
| 5 | Residues evaluation(3) | 2,028 |
Notes
(1) This category is mainly for active substances not currently approved in respect of the part of Great Britain to which the application relates. In certain cases it may also include active substances still being reviewed if toxicological endpoints have not yet been agreed and accepted in respect of that part of Great Britain.
(2) This category is for active substances where toxicological endpoints have already been agreed and accepted in respect of the part of Great Britain to which the application relates but the residue definition has only been established for crop groups unrelated to the intended use.
(3) This category is for active substances where relevant toxicological endpoints and residue definition have already been agreed and accepted in respect of the part of Great Britain to which the application relates.
Fees for multiple standalone applications for the same active substance are calculated on a modular basis with a charge applied for each crop or combination of maximum residue levels.]
Textual Amendments
F13Sch. 2 para. 2 inserted (31.12.2020) by S.I. 2019/720, reg. 1(2), Sch. 1 para. 15(6) (as amended by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 1 para. 11(3)(a)(b)); 2020 c. 1, Sch. 5 para. 1(1)
Options/Help
Print Options
PrintThe Whole Instrument
PrintThis Schedule only
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
See additional information alongside the content
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Opening Options
Different options to open legislation in order to view more content on screen at once
Explanatory Memorandum
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as enacted version that was used for the print copy
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Impact Assessments
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
- Why the government is proposing to intervene;
- The main options the government is considering, and which one is preferred;
- How and to what extent new policies may impact on them; and,
- The estimated costs and benefits of proposed measures.
Timeline of Changes
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as made version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.